Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Unknown 4 Recruiting 2 Not yet recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1277 Carcinoma, Non-Small-Cell Lung 926 Prostatic Neoplasms 729 Neoplasms 632 Multiple Myeloma 553 Lymphoma 539 Colorectal Neoplasms 529 Lung Neoplasms 515 Leukemia 497 Leukemia, Myeloid, Acute 472 Neoplasm Metastasis 470 Melanoma 425 Lymphoma, Non-Hodgkin 417 Ovarian Neoplasms 416 Leukemia, Lymphocytic, Chronic, B-Cell 386 Pancreatic Neoplasms 373 Recurrence 335 Precursor Cell Lymphoblastic Leukemia-Lymphoma 327 Head and Neck Neoplasms 306 Lymphoma, Large B-Cell, Diffuse 294 Glioblastoma 294 Myelodysplastic Syndromes 287 Brain Neoplasms 287 Lymphoma, Follicular 286 Stomach Neoplasms 280 Carcinoma, Renal Cell 268 Hodgkin Disease 261 Carcinoma, Hepatocellular 261 Rectal Neoplasms 256 Sarcoma 250

Interventions

atezolizumab 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Locally Advanced Cervical Cancer × Clear all

NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡